These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

529 related articles for article (PubMed ID: 20939439)

  • 1. Dronedarone. atrial fibrillation: too many questions about long-term adverse effects.
    Prescrire Int; 2010 Aug; 19(108):149-52. PubMed ID: 20939439
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dronedarone: an emerging therapy for atrial fibrillation.
    Rosei EA; Salvetti M
    Ther Adv Cardiovasc Dis; 2010 Jun; 4(3):155-64. PubMed ID: 20418270
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dronedarone: a new antiarrhythmic agent for the treatment of atrial fibrillation.
    Garcia D; Cheng-Lai A
    Cardiol Rev; 2009; 17(5):230-4. PubMed ID: 19690474
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dronedarone or amiodarone for rhythm control for atrial fibrillation: implications from the DIONYSOS study.
    Pamukcu B; Lip GY
    Expert Opin Pharmacother; 2010 Dec; 11(17):2775-8. PubMed ID: 21050033
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antiarrhythmic drugs for atrial fibrillation: focus on dronedarone.
    Krishnamoorthy S; Lip GY
    Expert Rev Cardiovasc Ther; 2009 May; 7(5):473-81. PubMed ID: 19419255
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Atrial fibrillation: rate control often better than rhythm control.
    Prescrire Int; 2004 Apr; 13(70):64-9. PubMed ID: 15148984
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dronedarone: an amiodarone analog for the treatment of atrial fibrillation and atrial flutter.
    Dale KM; White CM
    Ann Pharmacother; 2007 Apr; 41(4):599-605. PubMed ID: 17389667
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and safety of dronedarone: a review of randomized trials.
    Christiansen CB; Torp-Pedersen C; Køber L
    Expert Opin Drug Saf; 2010 Jan; 9(1):189-99. PubMed ID: 20001756
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dronedarone for maintenance of sinus rhythm in atrial fibrillation or flutter.
    Singh BN; Connolly SJ; Crijns HJ; Roy D; Kowey PR; Capucci A; Radzik D; Aliot EM; Hohnloser SH;
    N Engl J Med; 2007 Sep; 357(10):987-99. PubMed ID: 17804843
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative efficacy of dronedarone and amiodarone for the maintenance of sinus rhythm in patients with atrial fibrillation.
    Piccini JP; Hasselblad V; Peterson ED; Washam JB; Califf RM; Kong DF
    J Am Coll Cardiol; 2009 Sep; 54(12):1089-95. PubMed ID: 19744618
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dronedarone for atrial fibrillation therapy.
    Marzocchi M; Lombardi F
    Expert Rev Cardiovasc Ther; 2011 Jun; 9(6):675-83. PubMed ID: 21714598
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dronedarone: an emerging agent with rhythm- and rate-controlling effects.
    Wegener FT; Ehrlich JR; Hohnloser SH
    J Cardiovasc Electrophysiol; 2006 Sep; 17 Suppl 2():S17-20. PubMed ID: 16939434
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dronedarone: current evidence and future questions.
    Schafer JA; Kjesbo NK; Gleason PP
    Cardiovasc Ther; 2010; 28(1):38-47. PubMed ID: 20074258
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A review of the appropriate and inappropriate use of dronedarone: lessons learned from controlled studies and regulatory submission.
    Naccarelli GV; Wolbrette DL; Samii S; Banchs JE; Penny-Peterson E; Gonzalez MD
    J Cardiovasc Pharmacol Ther; 2010 Dec; 15(4 Suppl):24S-30S. PubMed ID: 21098416
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dronedarone: a novel antiarrhythmic agent for the treatment of atrial fibrillation.
    Duray GZ; Ehrlich JR; Hohnloser SH
    Curr Opin Cardiol; 2010 Jan; 25(1):53-8. PubMed ID: 19881340
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dronedarone: a new antiarrhythmic agent.
    Oyetayo OO; Rogers CE; Hofmann PO
    Pharmacotherapy; 2010 Sep; 30(9):904-15. PubMed ID: 20795846
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rhythm- and rate-controlling effects of dronedarone in patients with atrial fibrillation (from the ATHENA trial).
    Page RL; Connolly SJ; Crijns HJ; van Eickels M; Gaudin C; Torp-Pedersen C; Hohnloser SH;
    Am J Cardiol; 2011 Apr; 107(7):1019-22. PubMed ID: 21296333
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dronedarone: an overview.
    Kozlowski D; Budrejko S; Lip GY; Mikhailidis DP; Rysz J; Raczak G; Banach M
    Ann Med; 2012 Feb; 44(1):60-72. PubMed ID: 21745093
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A short-term, randomized, double-blind, parallel-group study to evaluate the efficacy and safety of dronedarone versus amiodarone in patients with persistent atrial fibrillation: the DIONYSOS study.
    Le Heuzey JY; De Ferrari GM; Radzik D; Santini M; Zhu J; Davy JM
    J Cardiovasc Electrophysiol; 2010 Jun; 21(6):597-605. PubMed ID: 20384650
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A review of the investigational antiarrhythmic agent dronedarone.
    Tafreshi MJ; Rowles J
    J Cardiovasc Pharmacol Ther; 2007 Mar; 12(1):15-26. PubMed ID: 17495254
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.